Global Hospital & Biosimilars Health System Director West

Role Summary

Global Hospital & Biosimilars Health System Director West leads pricing and contracting discussions with Key Accounts to support the biosimilar portfolio. This role collaborates with cross-functional teams and HQ partners to develop and execute strategic account plans, secure formulary access, and drive pull-through across hospital and biosimilar opportunities. The Director engages executive and administrative stakeholders within HSD accounts, including Directors of Pharmacy and P&T Committees, to communicate pricing/value propositions and align with strategic objectives. The role also contributes to regional hospital and biosimilar strategies and participates as a cross-functional team member to maximize portfolio impact within assigned accounts.

Responsibilities

• Appropriate communication and collaboration with cross-functional colleagues to support effective pricing/contracting discussions with Hospital & Biosimilars Key Accounts.
• Develop and execute focused, strategic account plans for all assigned accounts, emphasizing compliant contracting and contract pull-through.
• Engage executive and administrative level customer targets with pricing/value messages in support of the full Hospital & Biosimilars portfolio when directed by leadership.
• Support the development/execution of contracting strategy for the full Biosimilars portfolio by representing the needs and perspectives of HSD accounts to HQ-based functions.
• Comply with Corporate Policies and Procedures while maintaining integrity and high standards of business conduct.

Qualifications

• Required: 8 years of progressive experience in pharmaceutical sales, medical affairs, and/or corporate account management with customer-facing responsibilities.
• Required: 3–5 years of direct biosimilars and Generic Sterile Injectables experience, including buy-and-bill strategies, with knowledge of regulatory pathways (FDA, EMA, Health Canada) and interchangeability requirements.
• Required: Manufacturing and quality standards for biologics and generic sterile injectables, including comparability exercises; commercialization strategies, market access, IDN negotiations, and formulary inclusion for biosimilars; pharmacovigilance and post-market safety monitoring.
• Preferred: Oncology and/or Immunology & Inflammation therapeutic area expertise.
• Preferred: Proven success engaging Academic Medical Centers, IDNs, and large group practice community accounts.
• Preferred: Strong understanding of evolving US healthcare landscape and impact on provider accounts; strong financial acumen and ability to deliver pricing/value messages in a compliant fashion.
• Preferred: Demonstrated ability to engage executive/administrative personnel at large accounts and deliver customer impact; strategic thinking and ability to develop and monitor stakeholder business plans.
• Preferred: Experience in leading cross-functional teams and managing complex programs/projects.

Education

• Bachelor’s Degree required
• MBA or relevant graduate degree preferred

Skills

• Business Acumen: Knowledge of evolving healthcare market; ability to manage executive relationships; account management and negotiation skills.
• Financial Acumen
• Market and Business Strategy
• Account and Customer Management
• Functional Knowledge

Additional Requirements

• Data Analytics and interpretation; strategic perspective and planning; critical and analytical thinking; execution and measurement of outcomes.
• Relationship Management: value proposition management, networking, stakeholder management, influencing and leading without authority.
• Driving Ownership Culture: commitment to compliance, accountability, and adaptability; change agent for innovative moves.
• Geography includes Washington, Oregon, California, Nevada, Utah, Arizona, New Mexico, Texas, Oklahoma, Kansas, Colorado, Wyoming, Idaho, Montana.